Results 11 to 20 of about 82,028 (251)
Vancomycin-Resistant Enterococci [PDF]
Clinical Microbiology Reviews, 2000 SUMMARYAfter they were first identified in the mid-1980s, vancomycin-resistant enterococci (VRE) spread rapidly and became a major problem in many institutions both in Europe and the United States. Since VRE have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available ...
Y, Cetinkaya, P, Falk, C G, Mayhall
openaire +4 more sources
Detection of Vancomycin Resistance among Enterococcus faecalis and Staphylococcus aureus [PDF]
Journal of Clinical and Diagnostic Research, 2016 Introduction: Vancomycin remains the drug of choice for resistant gram positive infections caused by Enterococcus spp and Methicillin resistant Staphylococcus aureus (MRSA). Increased use of vancomycin has led to frank resistance and increase in MIC (
Ramya Rengaraj +3 more
doaj +1 more source
Vancomycin resistant enterococci [PDF]
Burns, 1998 In a previous commentary, we made the case that the fear of methicillin resistant Stnpl~yZc~occus QZLY~US (MRSA) in their burn units caused some clinicians to use vancomycin, inappropriately, as a first line antibiotic to treat patients with clinical signs of sepsis in the absence of microbiological evidence that the patient was, indeed, infected with ...
I A, Holder, A N, Neely
openaire +4 more sources
Journal of Pure and Applied Microbiology, 2021 Vancomycin-resistant enterococci (VRE) have emerged as an important nosocomial infection. Three important vancomycin resistance types namely, VanA, VanB, VanC are very commonly found in enterococci.
Deepa Devhare
doaj +1 more source
Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom [PDF]
Investigative and Clinical Urology, 2016 Purpose: Enterococci are a common cause of urinary tract infection and vancomycin-resistant strains are more difficult to treat. The purpose of this surveillance program was to assess the prevalence of and determine the risk factors for vancomycin ...
Liam Toner +5 more
doaj +1 more source
Vancomycin-resistantEnterococcus
Swiss Medical Weekly, 2012 The reported prevalence of vancomycin-resistant Enterococcus faecium (VRE) in Switzerland for the years 2008–2010 has been low at <5%. At the University Hospital Zurich, 17 cases of VRE were detected between 28 December 2009 and 15 February 2010. Nine cases were diagnosed clinically; eight cases were detected by rectal screening. The centre of
Thierfelder, C +6 more
openaire +5 more sources
Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains. [PDF]
PLoS ONE, 2012 Glycopeptides are still the gold standard to treat MRSA (Methicillin Resistant Staphylococcus aureus) infections, but their widespread use has led to vancomycin-reduced susceptibility [heterogeneous Vancomycin-Intermediate-Staphylococcus aureus (hVISA ...
Viviana Cafiso +7 more
doaj +1 more source
Antibiotics, 2023 Vancomycin and daptomycin are first-line drugs for the treatment of complicated methicillin-resistant Staphylococcus aureus (MRSA) infections, including bacteremia.
Vladimir Gostev +9 more
doaj +1 more source
Frontiers in Microbiology, 2022 Daptomycin (DAP), a last-resort antibiotic for treating Gram-positive bacterial infection, has been widely used in the treatment of vancomycin-resistant enterococci (VRE).
Weiwei Li +10 more
doaj +1 more source
Kurdistan Journal of Applied Research, 2020 Antibiotic resistance has become a major world health challenge and has limited the ability of physician's treatment. Staphylococcus aureus the most notorious pathogens causes morbidity and mortality especially in burn patients.
Shawnm Ahmed Aziz
doaj +3 more sources